PreppinPeppers › Facts › Lab article

Ecnoglutide: Reference Overview and Reconstitution Notes

Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide.

TL;DR

Ecnoglutide (XW003) is an investigational GLP-1 receptor agonist peptide studied in metabolic and weight regulation research. It is not FDA-approved in the US.

Facts Index

Fact IDCategoryEntityAttributeValueSource
ecnoglutide:titleidentityEcnoglutide: Reference Overview and Reconstitution NotestitleEcnoglutide: Reference Overview and Reconstitution NotesLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:publishedidentityEcnoglutide: Reference Overview and Reconstitution Notespublished2026-08-15Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:last-reviewedidentityEcnoglutide: Reference Overview and Reconstitution Noteslast reviewed2026-10-05Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:authoridentityEcnoglutide: Reference Overview and Reconstitution NotesauthorPreppin' Peppers Editorial TeamLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:topicsidentityEcnoglutide: Reference Overview and Reconstitution NotestopicsInvestigational, researchLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:summarycontentEcnoglutide: Reference Overview and Reconstitution NotessummaryEcnoglutide (XW003) is an investigational GLP-1 receptor agonist peptide studied in metabolic and weight regulation research. It is not FDA-approved in the US.Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-1contentEcnoglutide: Reference Overview and Reconstitution NotessectionWhat It IsLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-2contentEcnoglutide: Reference Overview and Reconstitution NotessectionEcnoglutideLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-3contentEcnoglutide: Reference Overview and Reconstitution NotessectionWhat it isLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-4contentEcnoglutide: Reference Overview and Reconstitution NotessectionResearch context and categorizationLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-5contentEcnoglutide: Reference Overview and Reconstitution NotessectionStatusLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-6contentEcnoglutide: Reference Overview and Reconstitution NotessectionReconstitution notes (general)Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-7contentEcnoglutide: Reference Overview and Reconstitution NotessectionDilution and handling notes (compound-specific)Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-8contentEcnoglutide: Reference Overview and Reconstitution NotessectionHandling and storageLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-9contentEcnoglutide: Reference Overview and Reconstitution NotessectionRelated readingLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-10contentEcnoglutide: Reference Overview and Reconstitution NotessectionTools and suppliesLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:section-12contentEcnoglutide: Reference Overview and Reconstitution NotessectionWhat the research community gets wrong about ecnoglutideLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:product-gansulin-metal-peptide-penproductsEcnoglutide: Reference Overview and Reconstitution Notesreferences productGansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:product-gansulin-3ml-cartridgeproductsEcnoglutide: Reference Overview and Reconstitution Notesreferences productGansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pubmed-ncbi-nlm-nih-govsourceEcnoglutide: Reference Overview and Reconstitution NotescitesGuo et al., Mol Metab 2023: Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog - pubmed.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pubchem-ncbi-nlm-nih-govsourceEcnoglutide: Reference Overview and Reconstitution NotescitesNCBI PubChem CID 162625103: Ecnoglutide (C194H304N48O61) - pubchem.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pmc-ncbi-nlm-nih-govsourceEcnoglutide: Reference Overview and Reconstitution NotescitesZhu et al., Nat Commun 2026: Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial - pmc.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pubmed-ncbi-nlm-nih-gov-2sourceEcnoglutide: Reference Overview and Reconstitution NotescitesShirley, Drugs 2026: Ecnoglutide: First Approvals - pubmed.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pubmed-ncbi-nlm-nih-gov-3sourceEcnoglutide: Reference Overview and Reconstitution NotescitesHe et al., Lancet Diabetes Endocrinol 2025: Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial - pubmed.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)
ecnoglutide:source-pmc-ncbi-nlm-nih-gov-2sourceEcnoglutide: Reference Overview and Reconstitution NotescitesKumar et al., Endocrinol Diabetes Metab 2026: Comparative Efficacy and Safety of Ecnoglutide in Type 2 Diabetes: A Systematic Review and Meta-Analysis - pmc.ncbi.nlm.nih.govLab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide) (evidence)

FAQ

What is ecnoglutide (XW003) and how does it work?
Ecnoglutide (XW003) is a long-acting, lipidated GLP-1 receptor agonist from Sciwind Biosciences, built from natural amino acids. Fatty-acid conjugation extends its half-life; it activates the GLP-1 receptor with a cAMP-biased signaling profile.
Is ecnoglutide FDA-approved in the United States?
No. Ecnoglutide is investigational and not FDA-approved in the U.S. It has received NMPA marketing approval in China for weight management, but that foreign-market status does not apply to or predict any FDA regulatory action.
Is ecnoglutide prohibited in sport under WADA rules?
Ecnoglutide is not specifically named on the WADA Prohibited List. GLP-1 receptor agonists as a class appear on WADA's Monitoring Program—tracked in testing but not currently sanctioned—while the class remains under ongoing review.